• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

齿叶橐吾水提物对实验性大鼠肝硬化的保肝作用及机制。

Hepatoprotective effects and mechanisms of Ixeris denticulate water extract on liver cirrhosis in experimental rat.

机构信息

Department of Infectious Diseases, Tongde Hospital of Zhejiang Province, No. 234 Gucui Road, Xihu District, Hangzhou, 321012, China.

出版信息

BMC Complement Med Ther. 2020 Jun 5;20(1):175. doi: 10.1186/s12906-020-02957-w.

DOI:10.1186/s12906-020-02957-w
PMID:32503634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7275494/
Abstract

BACKGROUND

To explore the protective effect and mechanisms of Ixeris denticulate water extract (IDWE) in the development of liver cirrhosis in experimental rat.

METHODS

Sixty rats were randomly divided into five groups: control group, model group and IDWE (2, 4 and 8 g/kg) treatment groups. Alanine transferase (ALT), aspartate transaminase (AST), albumin (ALB), tumor necrosis factor-alpha (TNF-α), Interleukin (IL)-6 and IL-8 in serum and superoxide dismutase (SOD), malondialdehyde (MDA) in liver tissue were evaluated, respectively. The liver index, liver morphology and liver histopathological analysis were detected as a supportive data. The liver protein expression of Bcl-2 and Bax were assessed by western blot, and NF-κB p65 protein expression was determined by immunohistochemistry analysis.

RESULTS

The result showed that a significantly decrease in the levels of serum AST, ALT and serum inflammatory factors TNF-α, IL-6 and IL-8 in IDWE-treated rats. The levels of serum ALB and SOD in liver tissue were markedly increased after IDWE treated, compared with model rats. Furthermore, IDWE-treated group also exhibited a down-regulated protein expression of NF-κB p65 and Bax, up-regulated Bcl-2 protein expression.

CONCLUSIONS

IDWE could effectively alleviate the course of liver cirrhosis in rat model, which may be a potent hepatoprotective agent in clinical therapy in the future.

摘要

背景

探讨菊三七水提物(IDWE)在实验性大鼠肝硬化发展中的保护作用及其机制。

方法

60 只大鼠随机分为 5 组:对照组、模型组和 IDWE(2、4 和 8g/kg)治疗组。分别检测血清丙氨酸转氨酶(ALT)、天门冬氨酸转氨酶(AST)、白蛋白(ALB)、肿瘤坏死因子-α(TNF-α)、白细胞介素(IL)-6 和 IL-8 以及肝组织中超氧化物歧化酶(SOD)、丙二醛(MDA)。检测肝指数、肝形态和肝组织病理分析作为辅助数据。采用 Western blot 法检测肝组织中 Bcl-2 和 Bax 的蛋白表达,免疫组化法检测 NF-κB p65 蛋白表达。

结果

结果表明,IDWE 治疗组大鼠血清 AST、ALT 及血清炎症因子 TNF-α、IL-6 和 IL-8 水平显著降低。与模型组相比,IDWE 治疗组大鼠血清 ALB 和肝组织 SOD 水平明显升高。此外,IDWE 治疗组还表现出 NF-κB p65 和 Bax 蛋白表达下调,Bcl-2 蛋白表达上调。

结论

IDWE 能有效缓解大鼠肝硬化的病程,有望成为未来临床治疗的有效肝保护剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b9/7275494/be69583035e0/12906_2020_2957_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b9/7275494/7a106f30ceb7/12906_2020_2957_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b9/7275494/74dfb1922a4f/12906_2020_2957_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b9/7275494/11f78b5bb790/12906_2020_2957_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b9/7275494/3e7266052bd9/12906_2020_2957_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b9/7275494/be69583035e0/12906_2020_2957_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b9/7275494/7a106f30ceb7/12906_2020_2957_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b9/7275494/74dfb1922a4f/12906_2020_2957_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b9/7275494/11f78b5bb790/12906_2020_2957_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b9/7275494/3e7266052bd9/12906_2020_2957_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b9/7275494/be69583035e0/12906_2020_2957_Fig5_HTML.jpg

相似文献

1
Hepatoprotective effects and mechanisms of Ixeris denticulate water extract on liver cirrhosis in experimental rat.齿叶橐吾水提物对实验性大鼠肝硬化的保肝作用及机制。
BMC Complement Med Ther. 2020 Jun 5;20(1):175. doi: 10.1186/s12906-020-02957-w.
2
The hepatoprotective effects of Sedum sarmentosum extract and its isolated major constituent through Nrf2 activation and NF-κB inhibition.松果菊提取物及其主要成分通过 Nrf2 激活和 NF-κB 抑制的保肝作用。
Phytomedicine. 2019 Feb;53:263-273. doi: 10.1016/j.phymed.2018.09.023. Epub 2018 Sep 3.
3
Protective effect of a polysaccharide from Anoectochilus roxburghii against carbon tetrachloride-induced acute liver injury in mice.金线莲多糖对四氯化碳诱导的小鼠急性肝损伤的保护作用。
J Ethnopharmacol. 2017 Mar 22;200:124-135. doi: 10.1016/j.jep.2017.02.018. Epub 2017 Feb 14.
4
Hepatoprotective effects of Cassia semen ethanol extract on non-alcoholic fatty liver disease in experimental rat.决明子乙醇提取物对实验性大鼠非酒精性脂肪肝病的保护作用。
Pharm Biol. 2019 Dec;57(1):98-104. doi: 10.1080/13880209.2019.1568509.
5
Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat.番茄红素对大鼠非酒精性脂肪性肝病的保肝及抗氧化作用
World J Gastroenterol. 2016 Dec 14;22(46):10180-10188. doi: 10.3748/wjg.v22.i46.10180.
6
Effect of salvia miltiorrhizae on apoptosis and NF-kappaB p65 expression in the liver of rats with severe acute pancreatitis or obstructive jaundice.丹参对重症急性胰腺炎或梗阻性黄疸大鼠肝脏细胞凋亡及核因子-κB p65表达的影响
J Gastroenterol Hepatol. 2009 May;24(5):841-52. doi: 10.1111/j.1440-1746.2008.05692.x. Epub 2008 Dec 2.
7
Polyprenols from Taxus chinensis var. mairei prevent the development of CCl₄-induced liver fibrosis in rats.马氏南方红豆杉中的多萜醇可预防 CCl₄ 诱导的大鼠肝纤维化的发展。
J Ethnopharmacol. 2012 Jun 26;142(1):151-60. doi: 10.1016/j.jep.2012.04.030. Epub 2012 Apr 21.
8
[Study of coenzyme Q10 in the liver of preeclampsia pregnant rats].[子痫前期孕鼠肝脏中辅酶Q10的研究]
Zhonghua Fu Chan Ke Za Zhi. 2016 Aug 25;51(8):608-15. doi: 10.3760/cma.j.issn.0529-567X.2016.08.011.
9
Hepatoprotective effects of a traditional Chinese medicine formula against carbon tetrachloride-induced hepatotoxicity in vivo and in vitro.一种中药配方对体内和体外四氯化碳诱导的肝毒性的保肝作用。
Biomed Pharmacother. 2019 Sep;117:109190. doi: 10.1016/j.biopha.2019.109190. Epub 2019 Jul 4.
10
Protective Effects of Ethyl Acetate Soluble Fraction of Limonium tetragonum on Diethylnitrosamine-Induced Liver Fibrosis in Rats.盐角草乙酸乙酯可溶部位对二乙基亚硝胺诱导的大鼠肝纤维化的保护作用
Biol Pharm Bull. 2016;39(6):1022-8. doi: 10.1248/bpb.b15-01047.

引用本文的文献

1
Structure Modification Converts the Hepatotoxic Tacrine into Novel Hepatoprotective Analogs.结构修饰将肝毒性他克林转化为新型肝保护类似物。
ACS Omega. 2024 Jan 2;9(2):2491-2503. doi: 10.1021/acsomega.3c07126. eCollection 2024 Jan 16.
2
The Influence of Extract on Growth Performance, Intestinal Barrier Function, and Metabolism of Growing Chickens.提取物对生长鸡生长性能、肠道屏障功能及代谢的影响
Animals (Basel). 2023 Jun 25;13(13):2108. doi: 10.3390/ani13132108.
3
Neutrophil extracellular traps are associated with enhanced procoagulant activity in liver cirrhosis patients with portal vein thrombosis.

本文引用的文献

1
Effects and mechanisms of iridoid glycosides from Patrinia scabiosaefolia on improving insulin resistance in 3T3-L1 adipocytes.白花败酱草中环烯醚萜苷对改善 3T3-L1 脂肪细胞胰岛素抵抗的作用及机制。
Food Chem Toxicol. 2019 Dec;134:110806. doi: 10.1016/j.fct.2019.110806. Epub 2019 Sep 12.
2
A novel model for predicting posthepatectomy liver failure in patients with hepatocellular carcinoma.一种用于预测肝细胞癌患者肝切除术后肝功能衰竭的新模型。
PLoS One. 2019 Jul 3;14(7):e0219219. doi: 10.1371/journal.pone.0219219. eCollection 2019.
3
Mitofusin2, as a Protective Target in the Liver, Controls the Balance of Apoptosis and Autophagy in Acute-on-Chronic Liver Failure.
中性粒细胞胞外诱捕网与伴有门静脉血栓形成的肝硬化患者增强的促凝活性相关。
J Clin Lab Anal. 2022 May;36(5):e24433. doi: 10.1002/jcla.24433. Epub 2022 Apr 18.
4
Geniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose, Inhibiting Apoptosis and Modulating Overall Metabolism.栀子苷通过减轻氧化应激和炎症反应、抑制细胞凋亡以及调节整体代谢来改善肝纤维化。
Front Pharmacol. 2021 Nov 24;12:772635. doi: 10.3389/fphar.2021.772635. eCollection 2021.
线粒体融合蛋白2作为肝脏中的一个保护性靶点,调控急性-on-慢性肝衰竭中细胞凋亡和自噬的平衡。
Front Pharmacol. 2019 May 31;10:601. doi: 10.3389/fphar.2019.00601. eCollection 2019.
4
Analysis on Effects of Comprehensive Nursing Care Applied in Interventional Therapy for Patients with Liver Cirrhosis and Liver Cancer.综合护理干预在肝硬化合并肝癌介入治疗中的效果分析
Iran J Public Health. 2019 Mar;48(3):494-500.
5
Predictive models of mortality and hospital readmission of patients with decompensated liver cirrhosis.失代偿期肝硬化患者死亡率和再入院率的预测模型。
Dig Liver Dis. 2019 Oct;51(10):1423-1429. doi: 10.1016/j.dld.2019.03.016. Epub 2019 May 18.
6
The Role of the CLIF-C OF and the 2016 MELD in Prognosis of Cirrhosis with and without Acute-on-Chronic Liver Failure.CLIF-C OF 和 2016 MELD 在伴有和不伴有慢加急性肝衰竭的肝硬化预后中的作用。
Ann Hepatol. 2019 Jan-Feb;18(1):48-57. doi: 10.5604/01.3001.0012.7862.
7
Implications of Manganese in Chronic Acquired Hepatocerebral Degeneration.锰对慢性获得性肝脑变性的影响。
Ann Hepatol. 2019 Jan-Feb;18(1):274-278. doi: 10.5604/01.3001.0012.7938.
8
Biochemical and molecular-genetic indicators of inflammation and apoptosis in liver cirrhosis as an outcome of the progression of non-alcoholic steatohepatitis.作为非酒精性脂肪性肝炎进展结果的肝硬化中炎症和细胞凋亡的生化及分子遗传学指标。
Ter Arkh. 2019 May 16;91(4):21-27. doi: 10.26442/00403660.2019.04.000057.
9
Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study.肝硬化门静脉血栓形成的相关危险因素:一项病例对照研究。
Ter Arkh. 2019 Mar 18;91(2):73-81. doi: 10.26442/00403660.2019.02.000153.
10
Prognosis factors of survival in patients with liver cirrhosis and portal hypertension.肝硬化和门静脉高压患者生存的预后因素。
Ter Arkh. 2019 Mar 18;91(2):67-72. doi: 10.26442/00403660.2019.02.000089.